The Usefulness of Monocyte-to-High Density Lipoprotein and Neutrophil-to-Lymphocyte Ratio in Diabetic Macular Edema Prediction and Early anti-VEGF Treatment Response
dc.authorid | Bozali, Erman/0000-0001-7918-8381 | |
dc.authorid | Erdogan, Haydar/0000-0002-9337-6968 | |
dc.authorid | Yalinbas, Duygu/0000-0001-9001-0277 | |
dc.contributor.author | Yeter, Duygu Yalinbas | |
dc.contributor.author | Eroglu, Serap | |
dc.contributor.author | Sariakcali, Baris | |
dc.contributor.author | Bozali, Erman | |
dc.contributor.author | Ozec, Ayse Vural | |
dc.contributor.author | Erdogan, Haydar | |
dc.date.accessioned | 2024-10-26T18:04:18Z | |
dc.date.available | 2024-10-26T18:04:18Z | |
dc.date.issued | 2022 | |
dc.department | Sivas Cumhuriyet Üniversitesi | |
dc.description.abstract | Purpose: To determine the association of monocyte-to-high-density lipoprotein ratio (MHR) and neutrophil-to-lymphocyte ratio (NLR) with diabetic macular edema (DME) and early anti-VEGF treatment response. Material methods: This was a retrospective and cross-sectional study conducted with 143 patients with diabetes mellitus (53 diabetic retinopathy with DME, 38 diabetic retinopathy without DME, and 52 without diabetic retinopathy). Results: 13.9 was the best cutoff value to predict DME for MHR, and 2 was for NLR (59% and 75% sensitivity and 81% and 59% specificity, respectively). Logistic regression analysis showed that NLR >= 2 and MHR >= 13.9 were significantly associated with DME prediction. However, neither NLR >= 2 nor MHR >= 13.9 was associated with central retinal thickness(CRT) or best corrected visual acuity(BCVA) outcomes after anti-VEGF treatment. On the other hand, increased NLR was associated with inferior CRT outcomes. Conclusion: MHR and NLR were simple and cost-effective biomarkers to predict DME. Moreover, higher NLR may contribute to poor CRT outcomes. | |
dc.identifier.doi | 10.1080/09273948.2020.1849739 | |
dc.identifier.endpage | 906 | |
dc.identifier.issn | 0927-3948 | |
dc.identifier.issn | 1744-5078 | |
dc.identifier.issue | 4 | |
dc.identifier.pmid | 33596398 | |
dc.identifier.scopus | 2-s2.0-85101043463 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 901 | |
dc.identifier.uri | https://doi.org/10.1080/09273948.2020.1849739 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/28861 | |
dc.identifier.volume | 30 | |
dc.identifier.wos | WOS:000619052100001 | |
dc.identifier.wosquality | Q2 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Taylor & Francis Inc | |
dc.relation.ispartof | Ocular Immunology and Inflammation | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Diabetes | |
dc.subject | macular edema | |
dc.subject | retinopathy | |
dc.subject | inflammation | |
dc.subject | monocyte | |
dc.subject | high-density lipoprotein | |
dc.title | The Usefulness of Monocyte-to-High Density Lipoprotein and Neutrophil-to-Lymphocyte Ratio in Diabetic Macular Edema Prediction and Early anti-VEGF Treatment Response | |
dc.type | Article |